[1]
Atayık, E. and Aytekin, G. 2022. Safety of allergen immunotherapy in patients with SARS-CoV-2 infection. The European Research Journal. 8, 5 (Sep. 2022), 642–649. DOI:https://doi.org/10.18621/eurj.1086549.